CLINICAL_TRIALS
trial_result
· 2025-06-10
Clinical Trial Update: Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET [Phase 1]
Summary
A Phase 1 study of AlphaMedix™ in adults with SSTR-positive neuroendocrine tumors was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Orano Med LLC | Conditions: Neuroendocrine Tumor | Phase 1 | Status: TERMINATED